Skip to main content

Table 1 The clinicopathologic factors of solitary HBV-related HCC patients who underwent initial hepatectomy (n = 1760)

From: Reclassification of tumor size for solitary HBV-related hepatocellular carcinoma by minimum p value method: a large retrospective study

Parameter Value
Age, years 50.7 ± 10.2
Sex  
 Male 1497 (85.1%)
 Female 263 (14.9%)
α-Fetoprotein, ng/mL  
 ≤ 20 726 (41.2%)
 20–400 451 (25.6%)
 ≥ 400 583 (33.1%)
HBV DNA, IU/ml  
 ≤ 1000 801 (45.5%)
 > 1000 959 (54.5%)
White blood cells, 109/L 5.26 ± 1.74
Platelet count, 109/L 152 (23-479)
Albumin, g/L 41.7 ± 3.74
Total bilirubin, μmol/L 13.4 (3.3–45.4)
γ-Glutamyl transferase, IU/L 55.0 (10–1175)
Alkaline phosphatase, IU/L 80.0 (17–1155)
ALBI grade  
 ≤ − 2.63 1270 (72.2%)
 > 2.63 490 (27.8%)
Blood loss, mL
 < 800 1650 (93.8%)
 ≥ 800 110 (6.2%)
Tumor size, cm 5.55 ± 3.48
Differentiation degree
 I/II 295 (16.8%)
 III/IV 1465 (83.2%)
Microvascular invasion
 Absent 1354 (76.9%)
 Present 406 (23.1%)
AJCC stage  
 T1a 121 (6.9%)
 T1b 1250 (71.0%)
 T2 389 (22.1%)
BCLC stage  
 0 121 (6.9%)
 A 1639 (93.1%)
Tumor capsule  
 Incomplete/absent 1232 (70.0%)
 Complete 528 (30.0%)
Cirrhosis  
 Absent 927 (52.7%)
 Present 833 (47.3%)
  1. Values shown are mean ± SD, median (range), or n (%)